Monday, 23 March 2020

Bayer, Curadev ink pact to discover drug candidates for lung, cardiovascular, inflammatory diseases

Global pharma and life sciences major Bayer and domestic drug
discovery firm Curadev have signed a research collaboration and
licence agreement to discover new drug candidates for treatment of
lung, cardiovascular and inflammatory diseases.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/bayer-curadev-ink-pact-to-discover-drug-candidates-for-lung-cardiovascular-inflammatory-diseases/articleshow/74775451.cms

No comments:

Post a Comment